Ovid Therapeutics (OVID) Shares Outstanding (2016 - 2026)

Ovid Therapeutics (OVID) Shares Outstanding (2016 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Qtr)
1	Oculis Holding AG	66,290.43 Bn	66,290.15 Bn	-	6,012.74 Bn
2	Nanobiotix	1,914.07 Bn	1,914.01 Bn	-	47.82 Bn
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-	118.76 Bn
4	BeOne Medicines	467.97 Bn	463.18 Bn	1.35 Bn	1.44 Bn
5	Vertex Pharmaceuticals	122.73 Bn	115.48 Bn	2.59 Bn	254.10 Mn
6	Regeneron Pharmaceuticals	70.42 Bn	61.67 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.82 Bn	62.82 Bn	-	400.00 Mn
8	Argenx Se	56.00 Bn	50.82 Bn	1.41 Bn	62.19 Mn
9	Alnylam Pharmaceuticals	37.51 Bn	34.50 Bn	959.66 Mn	132.89 Mn
10	Ovid Therapeutics	120.41 Mn	-35.11 Mn	-	50.07 Mn

Download Data